Czechia, Jan. 30 -- Czechia based Avenier a.s. has secured contract from Fakultni nemocnice Olomouc for Antineoplastic and immunomodulating agents - PEGINTERFERON BETA - 1A 2024. The value of the contract is worth 1677772710 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....